NYSE:FDSCapital Markets
FactSet Research Systems (FDS) Valuation Reassessed After AI Doc Ingest Launch For Cobalt Platform
FactSet Research Systems (FDS) has rolled out the beta version of AI Doc Ingest for its Cobalt platform, an AI-driven tool aimed at automating portfolio company data collection for private capital managers.
See our latest analysis for FactSet Research Systems.
The AI Doc Ingest launch lands at a tricky time for the stock, with the latest share price at $207.32 after a 30 day share price return of 29.59% decline and a 1 year total shareholder return of 55.07% decline. This points to fading...